12:00 AM
 | 
Jun 28, 2012
 |  BC Innovations  |  Distillery Therapeutics

Indication: Infectious disease

This week in therapeutics
Indication Target/marker/pathway Summary Licensing status Publication and contact information
Infectious disease
Pseudomonas Extended-spectrum b-lactamase (ESBL); Pseudomonas...

Read the full 181 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >